Download presentation
Presentation is loading. Please wait.
Published byLanny Hardja Modified over 5 years ago
1
Required Components of RA Disease Activity Measures for Point-of-Care Clinical Use
2
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
3
Non-TNF-Targeted DMARDs Approved for RA
4
ROC Trial Non-TNF vs Anti-TNF Treatment of RA After Failure of First Anti-TNF
5
Tofacitinib Meta-Analysis ACR Response Rates
6
ACR20 Response at Week 12 by Prior bDMARD
7
Selected Adverse Events Associated With Non-TNF-Targeted DMARDs
8
RA Response and Monitoring
9
Multidisciplinary Care for RA
10
Abbreviations
11
Abbreviations (cont)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.